Ivan Rizal Sini
Chairman presso PT DIAGNOS LABORATORIUM UTAMA TBK
Patrimonio netto: 6 M $ in data 29/02/2024
Profilo
Ivan Rizal Sini is a businessperson who has been the head of 9 different companies.
Dr. Sini occupies the position of President Commissioner of PT Diagnos Laboratorium Utama Tbk, President Commissioner for Pt Crm Bangun Husada, President Commissioner for Pt Bunda Global Pharma, President Commissioner at Pt Daima Citra Prima, Chairman for PT.
Moosa Genetika Farmindo, President Director at Pt Morula Indonesia, President Director at Pt Bunda Investama Indonesia, President Commissioner for PT Bundamedik Tbk (a subsidiary of Pt Bunda Investama Indonesia) and President Director at Pt Bunda Medika Wisesa.
Ivan Rizal Sini is also Member of Royal Australian College of Obstetricians & Gynaecologists.
Dr. Sini previously occupied the position of Director at Bunda Margonda Hospital.
He received a graduate degree from the University of Adelaide and a doctorate from the University of Indonesia.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PT BUNDAMEDIK TBK
3.24% | 30/06/2023 | 278 600 000 ( 3.24% ) | 6 M $ | 29/02/2024 |
Posizioni attive di Ivan Rizal Sini
Società | Posizione | Inizio |
---|---|---|
PT DIAGNOS LABORATORIUM UTAMA TBK | Chairman | 13/10/2020 |
PT BUNDAMEDIK TBK | Chairman | 01/01/2016 |
Pt Crm Bangun Husada | Chairman | 01/01/2018 |
Pt Bunda Global Pharma | Chairman | 01/01/2017 |
Pt Morula Indonesia
Pt Morula Indonesia Medical/Nursing ServicesHealth Services Pt Morula Indonesia operates as a fertility clinic. The private company is based in Jakarta, Indonesia. Ivan Rizal Sini has been the CEO of the Indonesian company since 2018. | Chief Executive Officer | 01/01/2018 |
Pt Bunda Investama Indonesia | Chief Executive Officer | 01/01/2014 |
Pt Bunda Medika Wisesa | Chief Executive Officer | 01/01/2016 |
Pt Daima Citra Prima | Chairman | 01/01/2018 |
Royal Australian College of Obstetricians & Gynaecologists | Corporate Officer/Principal | - |
░░ ░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Ivan Rizal Sini
Società | Posizione | Fine |
---|---|---|
░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Ivan Rizal Sini
University of Adelaide | Graduate Degree |
University of Indonesia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PT DIAGNOS LABORATORIUM UTAMA TBK | Health Services |
PT BUNDAMEDIK TBK | Health Services |
Aziende private | 9 |
---|---|
Royal Australian College of Obstetricians & Gynaecologists | |
Pt Crm Bangun Husada | |
Pt Bunda Global Pharma | |
Pt Morula Indonesia
Pt Morula Indonesia Medical/Nursing ServicesHealth Services Pt Morula Indonesia operates as a fertility clinic. The private company is based in Jakarta, Indonesia. Ivan Rizal Sini has been the CEO of the Indonesian company since 2018. | Health Services |
Pt Bunda Investama Indonesia | |
Pt Bunda Medika Wisesa | |
Pt Daima Citra Prima | |
Pt Moosa Genetika Farmindo
Pt Moosa Genetika Farmindo BiotechnologyHealth Technology PT. Moosa Genetika Farmindo is a biotechnology company based in Kota Jakarta Pusat, Indonesia. The Indonesian company specializes in cattle breeding and provides genetic improvement of regional cattle and dairy herds. Jeremia Michael Sutandy and Deddy F. Kurniawan have been the CEOs since 2016. The company was founded in 2016 by Prastowo Sigit, Arief Boediono, Deddy F. Kurniawan, Jeremia Michael Sutandy. | Health Technology |
Bunda Margonda Hospital |